Pegatrust (Pegaspargase Injection 5 ml, 3750 International units per 5ml In Pakistan

Pegatrust Pegaspargase Injection 3750 IU/5mL In Pakistan

Pegatrust Pegaspargase Injection 3750 International Units/5mL is a prescription anticancer medicine containing Pegaspargase as its active ingredient. It is an enzyme-based chemotherapy medicine primarily used as part of combination treatment protocols for acute lymphoblastic leukemia (ALL), a type of blood cancer.

Pegaspargase works by reducing the levels of asparagine, an amino acid required by certain leukemia cells for their growth and survival. It is administered under the supervision of a qualified oncologist in a specialized healthcare facility.

Composition

• Brand Name: Pegatrust

• Active Ingredient: Pegaspargase

• Strength: 3750 International Units (IU)

• Volume: 5mL

• Concentration: 750 IU/mL

• Dosage Form: Injection

• Drug Category: Antineoplastic Enzyme

• Therapeutic Class: Asparagine Depleting Agent

• Route of Administration: Intramuscular or intravenous, depending on the approved product labeling and treatment protocol

Uses of Pegatrust Pegaspargase Injection

Pegaspargase is primarily used as part of combination chemotherapy for acute lymphoblastic leukemia (ALL).

It may be prescribed for:

• Treatment of acute lymphoblastic leukemia (ALL).

• Pediatric ALL treatment protocols.

• Adult ALL treatment protocols in selected patients.

• Patients requiring asparaginase-based chemotherapy.

It may be used in newly diagnosed or relapsed ALL according to the patient's treatment plan and clinical condition.

How Pegaspargase Works

Pegaspargase is a modified enzyme that helps break down asparagine, an amino acid required by certain leukemia cells.

Some leukemia cells cannot produce enough asparagine themselves and depend on the supply available in the bloodstream. Pegaspargase reduces circulating asparagine levels, limiting the ability of these cancer cells to grow and survive.

The pegylated formulation helps extend the medicine's activity in the body.

Dosage and Administration

The dosage of Pegatrust Pegaspargase depends on the patient's age, body surface area, treatment protocol, clinical condition, and response to therapy.

• Administered by a qualified healthcare professional.

• May be given intramuscularly or intravenously according to the specific product instructions.

• Dosage and treatment intervals are determined by the treating oncologist.

• Regular laboratory monitoring is necessary.

• Treatment may be combined with other chemotherapy medicines.

Important: Pegatrust is a specialized chemotherapy medicine. It must not be self-administered and should only be used under specialist medical supervision.

Possible Side Effects

Pegaspargase may cause side effects, including:

• Nausea and vomiting

• Abdominal pain

• Loss of appetite

• Fatigue and weakness

• Allergic reactions

• Elevated liver enzymes

• Increased blood sugar levels

• Changes in blood clotting

• Pancreatitis

• Low levels of certain blood proteins

Serious complications may include severe allergic reactions, liver toxicity, pancreatitis, blood clots, and bleeding disorders.

Important Precautions

Before receiving Pegatrust Pegaspargase Injection, inform the treating oncologist about existing medical conditions, allergies, and all medicines being taken.

Important precautions include:

• Monitoring liver function.

• Monitoring blood glucose levels.

• Assessing pancreatic enzymes for signs of pancreatitis.

• Monitoring blood clotting parameters.

• Assessing for allergic or hypersensitivity reactions.

• Monitoring for signs of bleeding or blood clots.

Patients should immediately report severe abdominal pain, breathing difficulties, unusual bleeding, or signs of an allergic reaction.

Storage

Store Pegatrust Pegaspargase Injection according to the manufacturer's approved storage conditions and product labeling. Follow the recommended temperature requirements and protect the medicine from inappropriate handling.

Avoid freezing unless specifically permitted by the manufacturer's instructions. Follow the product-specific guidance for handling and storage after preparation.

Keep out of reach of children.

Pegatrust Pegaspargase Injection 3750 IU/5mL In Pakistan

Pegatrust Pegaspargase Injection 3750 International Units per 5mL is available at Onlinetrade.pk in Pakistan, subject to current stock and applicable prescription requirements.

Customers and healthcare professionals can contact Onlinetrade.pk for product availability and ordering information.

Availability in Pakistan

Pegatrust Pegaspargase Injection may be available in major cities of Pakistan, including Lahore, Karachi, Islamabad, Rawalpindi, Multan, Faisalabad, Peshawar, Gujranwala, Hyderabad, Bahawalpur, Sialkot, Sukkur, Larkana, and other major cities, subject to stock availability.

Frequently Asked Questions (FAQs)

What is Pegatrust Pegaspargase Injection used for?

Pegatrust contains Pegaspargase, an anticancer enzyme medicine primarily used in combination chemotherapy for acute lymphoblastic leukemia (ALL).

What is the strength of Pegatrust Injection?

The stated presentation contains 3750 International Units of Pegaspargase in 5mL, equivalent to 750 IU/mL.

How is Pegaspargase administered?

Depending on the approved product labeling and treatment protocol, it may be administered intramuscularly or intravenously by trained healthcare professionals.

Is Pegaspargase a chemotherapy medicine?

Yes. Pegaspargase is an enzyme-based antineoplastic medicine used as part of specialized leukemia treatment protocols.

What are the major precautions associated with Pegaspargase?

Important precautions include monitoring for allergic reactions, liver problems, pancreatitis, blood clots, bleeding complications, and changes in blood glucose.

Where can I find Pegatrust Pegaspargase Injection in Pakistan?

You can check its availability at Onlinetrade.pk, subject to current stock and applicable prescription requirements.